Menu
Back to Archived Journals » Reports in Medical Imaging » Volume 3
Technetium-99m tetrofosmin: Use for myocardial perfusion imaging in the detection of coronary artery disease
Authors D'Arceuil H
Published 13 August 2010 Volume 2010:3 Pages 1—10
DOI https://doi.org/10.2147/RMI.S7565
Review by Single anonymous peer review
Peer reviewer comments 3
Helen Erica D’Arceuil
Department of Radiology, Stanford University School of Medicine, California, USA
Abstract: Technetium-99m tetrofosmin is a radioactive tracer which is designed for myocardial perfusion imaging. Differential tracer uptake allows discrimination between normal and ischemic myocardium. Technetium-99m tetrofosmin has shown excellent utility as a safe, cost-effective, and technically sound agent for use in the diagnosis of coronary artery disease. This paper provides an overview of the available literature on clinical applications of technetium-99m tetrofosmin, and shows how this tracer has gained widespread acceptance as a diagnostic aid since its inception approximately 17 years ago. The various cardiac imaging modalities and imaging protocols which have employed this agent are also briefly reviewed.
Keywords: technetium-99m tetrofosmin, myocardial, viability, imaging
© 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.